spironolactone has been researched along with bromhexine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Bulanova, MM; Fuks, AA; Kamalov, AA; Malakhov, PS; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, EA; Orlova, YA; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Sinitsyn, VE | 1 |
Agapov, MA; Akopyan, ZA; Asratyan, DA; Begrambekova, YL; Bulanova, MM; Dyachuk, LI; Fuks, AA; Kamalov, АА; Mareev, VY; Mareev, YV; Matskeplishvili, ST; Mershina, ЕА; Orlova, YA; Pakhomov, PV; Pavlikova, EP; Plisyk, AG; Potapenko, AV; Samokhodskaya, LM; Seredenina, EM; Sinitsyn, VE | 1 |
1 trial(s) available for spironolactone and bromhexine
Article | Year |
---|---|
[Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)].
Topics: Bromhexine; Coronavirus Infections; COVID-19; Hospitalization; Humans; Prospective Studies; SARS-CoV-2; Spironolactone; Treatment Outcome | 2020 |
1 other study(ies) available for spironolactone and bromhexine
Article | Year |
---|---|
[Combination therapy at an early stage of the novel coronavirus infection (COVID-19). Case series and design of the clinical trial "BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)"].
Topics: Betacoronavirus; Bromhexine; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Hospitalization; Humans; Moscow; Pandemics; Pneumonia, Viral; Prospective Studies; Randomized Controlled Trials as Topic; SARS-CoV-2; Spironolactone | 2020 |